Flora Growth (FLGC) Peer Comparison
$9.59
$0.64
(7.15%)
As on 20-Mar-2026 09:30EDT
Market cap
$6 Mln
Revenue (TTM)
$15 Mln
P/E Ratio
--
P/B Ratio
0.3
Div. Yield
0 %
Edit
| Flora Growth (FLGC) | Bright Minds Biosciences Inc (DRUG) | Cybin (CYBN) | Oncolytics Biotech - ADR | |
|---|---|---|---|---|
Market cap ($ Mln) |
6 | 760 | 413 | 108 |
Revenue ($ Mln) |
15 | -- | -- | -- |
Net Profit ($ Mln) |
-4.43 | -24.75 | -131.58 | -38.21 |
Net Margin (%) |
-825.79 | -- | -- | -- |
RoE (%) |
-11.79 | -12.45 | -61.82 | -- |
Price to Earnings |
-- | -- | -- | -- |
Price-To-Book |
0.33 | 3.48 | 1.03 | 1,055.04 |
Cashflow ($ Mln)
| Flora Growth (FLGC) | Bright Minds Biosciences Inc (DRUG) | Cybin (CYBN) | Oncolytics Biotech - ADR | |
|---|---|---|---|---|
|
Cash From Operating Activities
|
-8.68 | -8.69 | -101.30 | -20.11 |
|
Cash Flow from Investing Activities
|
-3.46 | -- | -1.97 | -0.01 |
|
Cash from Financing Activities
|
11.35 | 85.57 | 20.20 | 14.12 |
|
Net Cash Inflow / Outflow
|
-- | -- | -- | -- |
Ratios
Profitability Ratios
| Flora Growth (FLGC) | Bright Minds Biosciences Inc (DRUG) | Cybin (CYBN) | Oncolytics Biotech - ADR | |
|---|---|---|---|---|
|
ROCE (%)
|
-6.61 | -27.85 | -42.74 | -2,206.47 |
|
ROE (%)
|
-11.79 | -27.93 | -42.76 | -7,467.16 |
|
ROA (%)
|
-5.66 | -27.02 | -40.36 | -188.03 |
|
EBIT Margin (%)
|
-- | -- | -- | -- |
|
Net Margin (%)
|
-30.52 | -- | -- | -- |
|
Cash Profit Margin (%)
|
-- | -- | -- | -- |
Growth Ratios
| Flora Growth (FLGC) | Bright Minds Biosciences Inc (DRUG) | Cybin (CYBN) | Oncolytics Biotech - ADR | |
|---|---|---|---|---|
|
Revenue Growth (%)
|
-0.76 | -- | -- | -- |
|
EBIT Growth (%)
|
-- | -- | -- | -- |
|
Net Profit Growth (%)
|
72.18 | -336.46 | -44.90 | -26.17 |
|
EPS Growth (%)
|
-0.21 | -1.83 | -7.54 | 0.07 |
|
Book Value Growth (%)
|
-- | -- | -- | -- |
Valuation Ratios
| Flora Growth (FLGC) | Bright Minds Biosciences Inc (DRUG) | Cybin (CYBN) | Oncolytics Biotech - ADR | |
|---|---|---|---|---|
|
Price / Earnings
|
-1.48 | -35.55 | -1.21 | -3.28 |
|
Price / Book Value
|
0.09 | 5.30 | 0.58 | -18.11 |
|
Dividend Yield (%)
|
-- | -- | -- | -- |
|
EV/EBITDA
|
-14.36 | -28.96 | -0.01 | -3.07 |
|
Market Cap ($ Cr)
|
-- | -- | -- | -- |
Solvency Ratios
| Flora Growth (FLGC) | Bright Minds Biosciences Inc (DRUG) | Cybin (CYBN) | Oncolytics Biotech - ADR | |
|---|---|---|---|---|
|
Debt to Equity
|
0.76 | 0.00 | -- | -0.15 |
|
Short term debt to equity ratio
|
0.04 | 0.00 | -- | -0.05 |
|
Current Ratio
|
1.01 | 36.10 | 7.75 | 1.12 |
|
Quick Ratio
|
0.79 | -- | -- | -- |
|
Interest Coverage
|
-99.57 | -475.09 | -- | -- |
Operating Efficiency Ratios
| Flora Growth (FLGC) | Bright Minds Biosciences Inc (DRUG) | Cybin (CYBN) | Oncolytics Biotech - ADR | |
|---|---|---|---|---|
|
Debtors to sales (%)
|
5.51 | -- | -- | -- |
|
Asset Turnover
|
0.19 | 0.00 | 0.00 | 0.00 |
|
Receivable days
|
102.04 | -- | -- | -- |
|
Inventory Days
|
170.49 | -- | -- | -- |
|
Payable days
|
173.24 | 7,007.85 | -- | 15,379.49 |
|
Cash Conversion Cycle
|
99.28 | -- | -- | -- |
loading...
loading...
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.
